ES2722425T3 - (2H)-2-Oxopiridinas como inhibidores del factor XIa para el tratamiento de enfermedades trombóticas - Google Patents
(2H)-2-Oxopiridinas como inhibidores del factor XIa para el tratamiento de enfermedades trombóticas Download PDFInfo
- Publication number
- ES2722425T3 ES2722425T3 ES15777625T ES15777625T ES2722425T3 ES 2722425 T3 ES2722425 T3 ES 2722425T3 ES 15777625 T ES15777625 T ES 15777625T ES 15777625 T ES15777625 T ES 15777625T ES 2722425 T3 ES2722425 T3 ES 2722425T3
- Authority
- ES
- Spain
- Prior art keywords
- trifluoromethyl
- difluoromethyl
- fluorine
- group
- difluoromethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuesto de fórmula **(Ver fórmula)** en la que R1 representa un grupo de fórmula **(Ver fórmula)** en la que * es el sitio de enlace al anillo de oxopiridina, R6 representa bromo, cloro, flúor, metilo, difluorometilo, trifluorometilo, metoxi, difluorometoxi, trifluorometoxi o metilamino, R7 representa bromo, cloro, flúor, ciano, nitro, hidroxi, metilo, difluorometilo, trifluorometilo, metoxi, etoxi, difluorometoxi, trifluorometoxi, etinilo, 3,3,3-trifluoroprop-1-in-1-ilo o ciclopropilo, R8 representa hidrógeno, cloro o flúor, R2 representa hidrógeno, bromo, cloro, flúor, ciano, alquilo C1-C3, difluorometilo, trifluorometilo, 1,1-difluoroetilo, 2,2-difluoroetilo, 2,2,2-trifluoroetilo, alcoxi C1-C3, difluorometoxi, trifluorometoxi, 1,1-difluoroetoxi, 2,2-difluoroetoxi, 2,2,2-trifluoroetoxi, metilcarbonilo o ciclopropilo, R3 representa hidrógeno, alquilo C1-C5, alcoxi C1-C4, difluorometilo, trifluorometilo, 1,1-difluoroetilo, 1,1,2,2,2- pentadeuteroetilo, 3,3,3-trifluoro-2-hidroxiprop-1-ilo, 3,3,3-trifluoro-2-metoxiprop-1-ilo, 3,3,3-trifluoro-2-etoxiprop- 1-ilo, prop-2-in-1-ilo, ciclopropiloxi o ciclobutiloxi, en el que alquilo puede estar sustituido con un sustituyente seleccionado del grupo que está constituido por flúor, ciano, hidroxi, difluorometilo, trifluorometilo, metoxi, etoxi, difluorometoxi, trifluorometoxi, cicloalquilo C3-C6, oxoheterociclilo de 4 a 6 miembros, 1,4-dioxanilo, oxazolilo, pirazolilo, oxadiazolilo, dihidro-oxazolilo, fenilo y piridilo, en el que cicloalquilo puede estar sustituido con 1 a 2 sustituyentes independientemente entre sí seleccionados del grupo que está constituido por flúor, hidroxi, metilo, etilo, metoxi, etoxi, difluorometilo, trifluorometilo, difluorometoxi y trifluorometoxi, y en el que oxo-heterociclilo puede estar sustituido con 1 a 2 sustituyentes independientemente entre sí seleccionados del grupo que está constituido por oxo, flúor, metilo, etilo, difluorometilo y trifluorometilo, y en el que oxazolilo, pirazolilo y oxadiazolilo pueden estar sustituidos con 1 a 2 sustituyentes independientemente entre sí seleccionados del grupo que está constituido por metilo y etilo, R4 representa hidrógeno, R5 representa un grupo de fórmula **(Ver fórmula)** en la que es el sitio de enlace al átomo de nitrógeno, R12 representa hidrógeno o flúor, R13 representa hidroxi o -NHR14, en el que R14 representa hidrógeno o alquilo C1-C4, o una de sus sales, sus solvatos o de los solvatos de sus sales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14186084 | 2014-09-24 | ||
PCT/EP2015/071660 WO2016046166A1 (de) | 2014-09-24 | 2015-09-22 | Substituierte oxopyridin-derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2722425T3 true ES2722425T3 (es) | 2019-08-12 |
Family
ID=51589182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES15777625T Active ES2722425T3 (es) | 2014-09-24 | 2015-09-22 | (2H)-2-Oxopiridinas como inhibidores del factor XIa para el tratamiento de enfermedades trombóticas |
Country Status (4)
Country | Link |
---|---|
US (1) | US10167280B2 (es) |
EP (1) | EP3197872B1 (es) |
ES (1) | ES2722425T3 (es) |
WO (1) | WO2016046166A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2722423T3 (es) * | 2014-09-24 | 2019-08-12 | Bayer Pharma AG | Derivados de oxopiridina sustituidos |
CN107428689A (zh) * | 2015-03-19 | 2017-12-01 | 拜耳制药股份公司 | 作为治疗血栓形成的因子xia抑制剂的氧代吡啶衍生物 |
JO3703B1 (ar) | 2015-07-09 | 2021-01-31 | Bayer Pharma AG | مشتقات أوكسوبيريدين مستبدلة |
CA3096480A1 (en) | 2018-04-10 | 2019-10-17 | Bayer Pharma Aktiengesellschaft | A substituted oxopyridine derivative |
ES2965494T3 (es) | 2018-04-12 | 2024-04-15 | Bayer Ag | Derivados de N-(ciclopropilmetil)-5-(metilsulfonil)-n-{1-[1-(pirimidin-2-il)-1H-1,2,4-triazol-5-il]etil}benzamida y los correspondientes derivados de piridina-carboxamida como plaguicidas |
WO2020127508A1 (en) | 2018-12-21 | 2020-06-25 | Bayer Aktiengesellschaft | Substituted oxopyridine derivatives |
WO2020127504A1 (en) | 2018-12-21 | 2020-06-25 | Bayer Aktiengesellschaft | Substituted oxopyridine derivatives |
JP7450024B2 (ja) * | 2019-09-27 | 2024-03-14 | シェンヅェン サルブリス ファーマシューティカルズ カンパニー リミテッド | FXIa阻害剤及びその調製方法と医薬用途 |
US11654036B2 (en) | 2020-05-26 | 2023-05-23 | Elixir Medical Corporation | Anticoagulant compounds and methods and devices for their use |
WO2022056326A1 (en) * | 2020-09-11 | 2022-03-17 | Elixir Medical Corporation | Anticoagulant compounds, methods and devices for ophthalmic use |
WO2022083707A1 (zh) * | 2020-10-23 | 2022-04-28 | 深圳信立泰药业股份有限公司 | FXIa抑制剂化合物或其盐的医药用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1526131A1 (en) * | 2003-10-22 | 2005-04-27 | Graffinity Pharmaceuticals Aktiengesellschaft | Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors |
GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
EP2091947A2 (en) | 2006-12-20 | 2009-08-26 | Takeda San Diego, Inc. | Glucokinase activators |
JP6033318B2 (ja) | 2011-10-14 | 2016-11-30 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 第XIa因子阻害剤としての置換テトラヒドロイソキノリン化合物 |
WO2014160592A2 (en) * | 2013-03-27 | 2014-10-02 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
TWI633089B (zh) | 2013-03-28 | 2018-08-21 | 拜耳製藥股份有限公司 | 經取代的酮基吡啶衍生物 |
EP3024822B1 (de) | 2013-07-23 | 2017-05-03 | Bayer Pharma Aktiengesellschaft | Substituierte oxopyridin-derivate und ihre verwendung als faktor xia und plasmakallikrein inhibitoren |
JP6368367B2 (ja) | 2013-10-30 | 2018-08-01 | バイエル ファーマ アクチエンゲゼルシャフト | 置換オキソピリジン誘導体 |
EP3138839B1 (en) | 2014-02-14 | 2020-10-28 | Sichuan Haisco Pharmaceutical Co., Ltd. | Pyridone or pyrimidone derivative, preparation method therefor and application thereof |
-
2015
- 2015-09-22 EP EP15777625.3A patent/EP3197872B1/de active Active
- 2015-09-22 US US15/513,977 patent/US10167280B2/en active Active
- 2015-09-22 ES ES15777625T patent/ES2722425T3/es active Active
- 2015-09-22 WO PCT/EP2015/071660 patent/WO2016046166A1/de active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US10167280B2 (en) | 2019-01-01 |
EP3197872B1 (de) | 2019-01-30 |
WO2016046166A1 (de) | 2016-03-31 |
EP3197872A1 (de) | 2017-08-02 |
US20170291892A1 (en) | 2017-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2722425T3 (es) | (2H)-2-Oxopiridinas como inhibidores del factor XIa para el tratamiento de enfermedades trombóticas | |
AR109805A1 (es) | Derivados de oxadiazol microbiocidas | |
AR118312A2 (es) | Pesticidas de azol bicíclico sustituido con heterociclos | |
AR108745A1 (es) | Derivados de oxadiazol microbiocidas | |
ES2722423T3 (es) | Derivados de oxopiridina sustituidos | |
PE20170939A1 (es) | Pirimidinonas como inhibidores del factor xia | |
CU24448B1 (es) | Compuestos de indazol sustituidos y compuestos intermediarios para la preparación de los mismos | |
CO2018005848A2 (es) | Compuestos de pirazol o sus sales, métodos de preparación de los mismos, composiciones herbicidas y su uso | |
CR20170118A (es) | Derivados espirodiamina como inhibidores de la aldosterona sintasa | |
CO6220951A2 (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso | |
SV2016005328A (es) | Nuevos derivados de pirazolo pirimidina y su uso como inhibidores de malt1 | |
AR067646A1 (es) | Ariloxazoles sustituidos y su uso | |
AR101816A1 (es) | Derivados de 3-[(pirazol-5-il)-heteroaril]-benzamidas como agentes pesticidas | |
ES2612259T3 (es) | Inhibidores de cinasa | |
PE20170677A1 (es) | Nuevos compuestos como inhibidores de reorganizado durante la transfeccion (ret) | |
AR095512A1 (es) | 4-amino-6-(heterocíclico)picolinatos y 6-amino-2-(heterocíclico)pirimidin-4-carboxilatos y su uso como herbicidas | |
AR076435A1 (es) | Compuestos de indazoles sustituidos, composiciones farmaceuticas que los contienen y procesos de obtencion de los mismos | |
ES2659397T3 (es) | 2-azabicíclicos sustituidos y su uso como moduladores receptores de orexinas | |
AR067058A1 (es) | Oxazolidinonas sustituidas y su uso para preparar medicamentos | |
ES2506169T3 (es) | Derivados de 5-fluoro-2-oxopirimidina-1(2H)-carboxilato como fungicidas | |
PE20161368A1 (es) | Inhibidores de diacilglicerol aciltranferasa 2 | |
AR083903A1 (es) | Derivados de benzooxazol y benzotiazol sulfonamidas, utiles para tratar trastornos del ritmo cardiaco y cancer, composiciones farmaceuticas que los contienen y metodo para prepararlos | |
AR070648A1 (es) | Derivados de bencimidazol sustituido | |
AR055744A1 (es) | Derivados de acido pirimidincarboxilico, su uso para preparar medicamentos y preparacion de dicjhos compuestos | |
AR103742A1 (es) | Derivados de trifluorometilpropanamida |